Literature DB >> 1644038

Benign breast lesions in Kenya: a histological study.

B Bjerregaard1, A Kung'u.   

Abstract

During 1981-85, 1084 cases of benign breast lesions were seen at Kenyatta National Hospital, Nairobi, Kenya. In the same period, 417 cases of breast carcinoma were diagnosed. Amongst the benign lesions fibroadenoma was the most common diagnosis (531 cases) followed by mastopathy (177 cases). The incidence rate of fibroadenoma was 1.6 per 100,000 person-years. Classic tubular adenoma was seen in 26 cases and in 26 cases a mixture of fibroadenoma and tubular adenoma was seen. These findings suggest that breast adenoma is probably one tumour with different expressions of the glandular and fibrous areas. We found no specific gross or microscopical features by which it was possible with certainty to distinguish between fibroadenoma and giant fibroadenoma and therefore suggest that the term giant fibroadenoma be avoided. The histopathologic pattern of mastopathy showed great variation, but the lesions were without difficulty divided into three main categories, i.e. cystic, fibrous and hyperplastic mastopathy. This distinction is important as cases with marked epithelial hyperplasia have been shown to have an increased cancer risk. Except for low parity no similarities in risk factors for mastopathy and breast cancer have been shown so far.

Entities:  

Mesh:

Year:  1992        PMID: 1644038

Source DB:  PubMed          Journal:  East Afr Med J        ISSN: 0012-835X


  2 in total

1.  Cytological evaluation of breast lesions in symptomatic patients presenting to Kenyatta National Hospital, Kenya: a retrospective study.

Authors:  Ken Munene Nkonge; Emily Adhiambo Rogena; Edwin Owino Walong; Dennis Karani Nkonge
Journal:  BMC Womens Health       Date:  2015-12-15       Impact factor: 2.809

2.  Fibroadenoma of the breast in a South African population -a pilot study of the diagnostic accuracy of fine needle aspirate cytology and breast ultrasonography.

Authors:  Sumana Pillay; Shalen Cheddie; Yoshan Moodley
Journal:  Afr Health Sci       Date:  2018-06       Impact factor: 0.927

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.